Prévention Information Lutte contre le Sida (PILS): Annual Report 2016


Prévention Information Lutte contre le Sida (PILS): Annual Report 2016

7 September 2017

Two main needs emerged from this revision. First, the importance of strengthening operational systems and linking services. The idea is to strengthen links with existing partners in the implementation of programmes which are already underway, to ensure that those reached on the field are redirected to the services offered by PILS or the government. On the one hand, PILS has revised its internal organisation in order to develop synergies between the various functions that comprise the association today. Particular attention is given to collaborative work, with the setting up of several committees within the association, so that everyone can contribute as much as possible to decision-making.

On the other is the strengthening of community systems and the involvement of communities at all stages of business processes and decision-making. This is reflected in the development of our community health services in 2017. This unit already offers de-medicalised and community-based screening services, as well as counseling and referral care services. In addition, a patient committee composed of community leaders will be set up, which will be at the heart of the reflections on the needs, priorities, implementation, management and evaluation of these services.

Our actions and efforts, I am sure, will be supported by the new government in Mauritius and the Minister of Health, who has demonstrated his willingness to work with civil society. We will never cease to say that only full collaboration between the different actors in the fight against AIDS can ensure an effective national response. We are also delighted with the reintroduction of the methadone induction program announced by the Minister of Health, and we are pleased that those who have been waiting for some for the past two years can finally participate in this harm reduction program.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.